FDA Approved: SPINRAZA — Supplemental Application (Biogen Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Spinraza (nusinersen) filed by Biogen, indicating an expanded or updated labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Muscular Atrophy

Drugs mentioned

• Spinraza (nusinersen)

Snippet

SUPPL AP for SPINRAZA (NUSINERSEN)